Stock symbol SYN is outdated, potentially delisted? Maybe it is available on other exchange? Monthly price history for SYN (Synthetic Biologics, Inc.). Synthetic Biologics Inc Stock Summary and Key Details NYSE MKT SYN: Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of. Institutional Ownership and Shareholders. Synthetic Biologics Inc (US:SYN) has 0 institutional owners and shareholders that have filed 13D/G or 13F forms with. Should You Buy or Sell Synthetic Biologics Stock? Get The Latest SYN Stock Analysis, Price Target, Earnings Estimates, and Headlines at MarketBeat. Synthetic Biologics (SYN) Overview. Read detailed company information including current share prices, financial summary, directors, announcements.
Should value investors buy Synthetic Biologics stock? (SYN) share price, free cash flow, and discounted present value analysis. Dividend capture strategy is based on SYN's historical data. Past performance is no guarantee of future results. Step 1: Buy SYN shares 1 day before the ex-. Get Synthetic Biologics Inc. (SYN) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding. Synthetics Biologics Inc Stock Price (Quote) ; 30 days, $, $, Friday, 27th Jan SYN stock ended at $ This is % more than the trading day. Synthetic Biologics Market Cap: M, Enterprise value: N/A, P/E: , PEG ratio: , EPS: , Revenue: N/A, EBITDA: M, Income: M. Synthetic Biologics Inc (SYN) last ex-dividend date was on ―. Synthetic Biologics Inc distributed ― per share that represents a ― dividend yield. View today's Theriva Biologics Inc stock price and latest TOVX news and analysis. Create real-time notifications to follow any changes in the live stock. Synthetic Biologics Trading Alerts and Improvement Suggestions ; Symbol, SYN ; Name, Synthetic Biologics ; Type, Stock ; Country. United States ; Exchange, NYSE. Synthetic Biologics Inc - United States Price History ; 6/11/, PM, , , , ; 6/11/, AM, , Check if SYN Stock has a Buy or Sell Evaluation. SYN Stock Price (NYSE), Forecast, Predictions, Stock Analysis and Synthetics Biologics Inc News. Buy Synthetic Biologics (SYN) Stock. See SYN stock price and Buy/Sell Synthetic Biologics. Discuss news and analysts' price predictions with the investor.
ROCKVILLE, Md., Sept. 30, (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics. Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the. Shares of Synthetic Biologics (SYN) are up 65% so far in due to high expectations for its gastrointestinal drugs. SYN. In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Synthetic Biologics (SYN - Research Report), with a price target of. The latest Synthetic Biologics stock prices, stock quotes, news, and TOVX history to help you invest and trade smarter. All information about Theriva Biologics (SYN) - stock price, quote chart, key statistics, dividends, company news and more. SYN - Synthetic Biologics Inc Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (AMEX). Synthetic Biologics Inc. Maxim Group Sticks to Its Buy Rating for Synthetic Biologics (SYN) McCarthy covers the Healthcare sector, focusing on stocks such as Adial Pharmaceuticals. Instrument Name Synthetic Biologics Inc Instrument Symbol (SYN-A). Instrument Exchange NYSE Arca · 1D1-Day · 5D5-Days · 1M1-Month · 3M3-Months · 6M6-Months · 1Y1-Year.
As of March 3, , the registrant had ,, shares of common stock outstanding. Documents incorporated by reference: None. The average price target for Synthetic Biologics Inc is $ This is based on 1 Wall Streets Analysts month price targets, issued in the past 3 months. Synthetic Biologics Announces Reverse Stock Split. July 15, ET | Source: ROCKVILLE, Md., July 15, (GLOBE NEWSWIRE) -- Synthetic. Synthetic Biologics share price and SYN stock charts. Free real-time prices, and the most active stock market forums in the UK. The following chart presents the relative strength of Synthetic Biologics (SYN) as compared to the S&P When the blue line in the chart is moving up, the.
SYN - Short squeeze stock short interest data and short selling information for shares of Synthetic Biologics Incorporated. Short interest stock data. Synthetic Biologics, Inc. is a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat. Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet.
block wallet | discovery stock forecast